IL10 and neoplasm: identified the role of FoxP3 in tumor malignancy, as the downregulation of FoxP3 inhibits proliferation, invasiveness, and metastasis of tumor cells, reduces IL-10 and TGF-β signaling, and blocks immune escape in CCA (91).